Gene · 6664
Papers2,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of the Philadelphia-like subgroup in Turkish pediatric patients with acute lymphoblastic leukemia. | Ann Hematol | 2026 | 41739208 | PubTator, text mining | PubMed |
| From Regeneration Failure to Functional Restoration: Unlocking the Neuronal-Intrinsic Regenerative Capacity as a Therapeutic Frontier for Optic Neuropathy and Glaucoma. | CNS Neurosci Ther | 2026 | 41721205 | PubTator, text mining | PubMed |
| Mantle Cell Lymphoma with Persistent Massive Pleural Effusions Requiring Invasive Mechanical Ventilation and Bilateral Continuous Thoracic Drainage. | Reports (MDPI) | 2026 | 41718289 | PubTator, text mining | PubMed |
| Early Reprogramming Intermediates Enable Direct Neuronal Conversion Via NGN2. | J Mol Neurosci | 2026 | 41632409 | PubTator, text mining | PubMed |
| Sox11 deficiency induces paravertebral muscle injury and scoliosis via Mlxipl upregulation. | Genes Dis | 2026 | 41624909 | PubTator, text mining | PubMed |
| Integrative Genomic Analysis Identifies THAP9 as a Human-Specific Regulator of Oligodendrocyte Differentiation. | J Neurochem | 2026 | 41612596 | PubTator, text mining | PubMed |
| Integrative single‑cell multi‑omics network analysis to elucidate epigenetic regulation in neurodevelopmental disorders. | SLAS Technol | 2026 | 41580083 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Derived microRNAs as Fluid Biomarkers in Neurodegenerative Diseases: A Systematic Review. | J Neurochem | 2026 | 41572495 | PubTator, text mining | PubMed |
| Biological heterogeneity in adult IRF4-rearranged large B-cell lymphoma: Stratification by age and anatomical site. | Hemasphere | 2026 | 41560848 | PubTator, text mining | PubMed |
| TP53 mutation heterogeneity reveals distinct prognoses in mantle cell lymphoma. | Ann Hematol | 2026 | 41559357 | PubTator, text mining | PubMed |
| A novel molecular classifier enabling identification and prediction on immunotherapeutic response for MYCN-low pediatric neuroblastoma. | Cell Oncol (Dordr) | 2026 | 41553393 | PubTator, text mining | PubMed |
| Marginal zone lymphoma presenting with chylous ascites: A rare clinical manifestation and successful treatment with orelabrutinib-rituximab. | SAGE Open Med Case Rep | 2026 | 41551116 | PubTator, text mining | PubMed |
| The Methylation Level of Circulating Tumor DNA Predicts Prognosis for Stage I-III Colorectal Cancer. | J Gastrointest Cancer | 2026 | 41537917 | PubTator, text mining | PubMed |
| Diagnostic value and role in promoting fracture healing of deregulated circulating miR-204 in patients with osteoporotic fractures. | J Orthop Surg Res | 2026 | 41535940 | PubTator, text mining | PubMed |
| SOX11 Is Regulated by EGFR-STAT3 and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. | Cells | 2026 | 41511366 | PubTator, text mining | PubMed |
| Acquired MYC rearrangement potentially associated with ibrutinib resistance in mantle cell lymphoma. | Virchows Arch | 2026 | 41339992 | PubTator, text mining | PubMed |
| Transcriptional regulation of human NMNAT2: insights from 3D genome sequencing and bioinformatics. | FEBS J | 2026 | 41241829 | PubTator, text mining | PubMed |
| Neurogenesis decreases in the offspring of mothers infected with influenza A virus. | Front Cell Infect Microbiol | 2025 | 41567998 | PubTator, text mining | PubMed |
| Stage-Specific Alternative Polyadenylation During Human Neural Differentiation Revealed by Integrated Long- and Short-Read Sequencing. | Biology (Basel) | 2025 | 41514865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6664/papers?page=3